Interpace Diagnostics Group, Inc. Investor Rights Agreements
3 Contracts & Agreements
- Form of Investor Rights Agreement by and between Interpace Biosciences, Inc. and 3K Limited Partnership, to be entered into at the closing of the Standby Purchase Commitment (Filed With SEC on January 3, 2022)
- Amended and Restated Investor Rights Agreement, dated as of January 15, 2020, by and among Interpace Biosciences, Inc., 1315 Capital II, L.P. and Ampersand 2018 Limited Partnership (Filed With SEC on January 17, 2020)
- Investor Rights Agreement, dated July 15, 2019, by and between Interpace Diagnostics Group, Inc. and Ampersand 2018 Limited Partnership (Filed With SEC on July 19, 2019)
